Determination of HCV genotype by direct sequence analysis of quantitative PCR products

Journal of Medical Virology

Volumn 69, Issue 2, 2003, Pages 202-206

  Gargiulo, Franco ^a   De Francesco, Maria Antonia ^b   Pinsi, Gabriele ^a   Pollara, Caterina ^a   Terlenghi, Luigina ^a   Perandin, Francesca ^b   Manca, Nino ^b  

^a Spedali Civili   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Assay; Hybridization; PCR; Sequence; Therapy

Indexed keywords

INTERFERON; VIRUS RNA;

ARTICLE; ASSAY; CHRONIC HEPATITIS; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYBRIDIZATION; MAJOR CLINICAL STUDY; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

5' UNTRANSLATED REGIONS; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

HEPATITIS C VIRUS;

EID: 12244263563     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10284     Document Type: Article

References (31)

1. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE. 1992. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905.
2. Buoro S, Pizzighella S, Boschetto R, Pellizari L, Cusan N, Bonagurdi R, Mengoli C, Caudai C, Paluda M, Valensin PE, Palù G. 1999. Typing of hepatitis C virus by a new method based on restriction fragment length polymorphism. Intervirology 42:1-8.
3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
4. Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J, for the International Hepatitis Interventional Therapy Group. 1998. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 339:1493-1499.
5. European Association for the Study of the Liver. 1999. EASL international consensus conference on hepatitis C. Consensus statement. J Hepatol 300:956-961.
6. Fattovich G, Ribero ML, Pantalena M, Diodati G, Almasio P, Nevens F, Tremolada F, Degos F, Rai J, Solinas A. 2001. Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe. J Viral Hepatol 8:206-216.
7. Forns X, Bukh J. 1998. Methods for determining hepatitis C virus genotype. Viral Hepatol Rev 4:1-19.
8. Gavier B, Martunez-Gonzulez MA, Riezu-Boj JI, Lasarte JJ, Garcia N, Civeira MP, Prieto J. 1997. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology 113:1647-1653.
9. Gayowsky T, Singh N, Marino IR, Vargas H, Wagener M, Wannstedt C, Morelli F, Laskus T, Fung JJ, Rakela J, Starzl TE. 1997. Hepatitis C virus genotypes in liver transplant recipients: impact on post-transplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 64:422-426.
10. Germer JJ, Rys PN, Thorvilson JN, Persing DH. 1999. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol 37:2625-2630.
11. Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB Jr, Wiesner R, Persing D. 1997. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 63:1419-1423.
12. Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. 2001. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 20:41-47.
13. Hayashi J, Kishihara Y, Yoshimura E, Tani Y, Yamaji K, Ikematsu H, Ishiki H, Kashiwagi H. 1995. Relationship of genotype to level of hepatitis C viremia determined by competitive polymerase chain reaction. J Infect 30:235-239.
14. Hopf U, Berg T, Konig V, Kuther S, Heuft HG, Lobeck H. 1996. Treatment of chronic hepatitis C with interferon alpha: long-term follow up and prognostic relevance of HCV genotypes. J Hepatol 24(suppl.2):67-73.
15. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. 1993. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 18:16.
16. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JY. 1995. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favourable long-term response in patients with chronic hepatitis C. J Med Virol 46:109-115.
17. Pageaux GP, Ducos J, Mondain AM, Costes V, Picot MC, Perrigault PF, Domergue J, Larrey D, Michel H. 1997. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection. Liver Transplant Surg 3:501-505.
18. Persing DH. 1993. In vitro nucleic acid amplification techniques In: Persing DH, Smith TF, Tenover FC, White TJ, editors. Diagnostic molecular microbiology principles and applications. 1st ed. Washington, DC: American Society for Microbiology. p 51-87.
19. Pozzato G, Moretti M, Croce LS, Sasso F, Kaneko S, Unoura M, Kobayashi K, Crovatto M, Santini G, Tiribelli C. 1995. Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to different viral strains. J Med Virol 45:445-450.
20. Saracco G, Sostegni R, Ghisetti V, Rocca G, Cariti G, Andreoni M, Tabone M, Roffi L, Calleri G, Ballare M, et al. 2000. Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre study. J Virol Hepatol 7:124-129.
21. Simmonds P. 1995. Variability of hepatitis C virus. Hepatology 21:570-583.
22. Smith DB, Mellor J, Jarvis LM, Davdson F, Kolberg J, Urdea M, Yap PL, Simmonds P, and the International HCV Collaborative Study Group. 1995. Variation of the hepatitis C virus 5′non-coding region: implications for secondary structure, virus detection and typing. J Gen Virol 76:1749-1761.
23. Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. 1996. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 34:2259-2266.
24. Thiers V, Jaffredo F, Tuveri R, Chodan N, Bréchot C. 1997. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping results. J Virol Methods 65:9-17.
25. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Suitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K. 1994. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 19:1088-1094.
26. Varadaraj K, Skinner DM. 1994. Denaturants or cosolvents improve the specificity of PCR amplification of a G + C-rich DNA using genetically engineered DNA polymerases. Gene 140:1-5.
27. Viazov S, Kuzin S, Paladi N, Tchernovetsky M, Isaeva E, Mazhul L, Vasichova F, Widell A, Roggendorf M. 1997. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Moldova, and Uzbekistan). J Med Virol 53:36-40.
28. Weiland O, Zhang YY, Widell A. 1993. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment. Scand J Infect Dis 25:25-30.
29. Winship PR. 1989. An improved method for directly sequencing PCR amplified material using dimethylsulfoxide. Nucleic Acids Res 17: 1266.
30. Yu ML, Chuang WL, Chen SC, Lin ZY, Hsieh MY, Wang LY, Chang WY. 1999. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA. J Clin Pathol 52:807-811.
31. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DR. 1996. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 125:634-639.